Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - imunológicos para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - imunológicos para felidae, - gatos - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. os começos de imunidade foram demonstrados uma semana após o curso de vacinação primária para rinotraqueíte, calicivírus, chlamydophila felis e componentes de panleucopenia. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunológicos para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Umoja wa Ulaya - Kireno - EMA (European Medicines Agency)

advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - lesões de radiação - detoxifying agents for antineoplastic treatment - lysakare é indicado para a redução dos renal exposição à radiação durante o peptídeo-receptor de radionuclídeos terapia (prrt) com lutetium (177lu) oxodotreotide em adultos.

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

ems s/a - acetilcisteÍna - expectorantes balsamicos e mucolitico

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

germed farmaceutica ltda - acetilcisteÍna - expectorantes balsamicos e mucolitico

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

momenta farmacÊutica ltda. - acetilcisteÍna - expectorantes balsamicos e mucolitico

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

momenta farmacÊutica ltda. - desloratadina - anti-histaminicos sistemicos

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

apis flora industrial e comercial ltda - mikania glomerata spreng. - fitoterapico simples; expectorantes

Brazili - Kireno - ANVISA (Agência Nacional de Vigilância Sanitária)

pharlab indÚstria farmacÊutica s.a. - cloridrato de bromexina - expectorantes balsamicos e mucolitico